Complete Filing Data
Bon Natural Life Ltd reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $58.00 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Bon Natural Life Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$2.0M | $398.2K | $4.6M | $6.2M | $4.6M | $3.0M | $2.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $18.7M | $23.8M | $29.5M | $29.9M | $25.5M | $18.2M | $16.4M |
| Research And Development Expense | $754.2K | $1.6M | $298.5K | $424.6K | $249.1K | $205.4K | $522.9K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent | -$298.9K | $1.1M | -$1.0M | -$2.9M | $612.8K | $450.2K | -$281.7K |
| Operating Income Loss | -$1.6M | $1.9M | $5.9M | $6.6M | $5.4M | $3.5M | $3.2M |
| Operating Expenses | $5.5M | $5.2M | $2.9M | $2.8M | $1.7M | $1.7M | $2.1M |
| Nonoperating Income Expense | -$86.8K | -$1.2M | -$363.6K | $969.3K | $29.8K | $186.4K | -$185.3K |
| Income Tax Expense Benefit | $339.4K | $351.2K | $1.0M | $1.3M | $820.9K | $556.3K | $427.2K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.7M | $715.9K | $5.6M | $7.6M | $5.4M | $3.7M | $3.0M |
| Gross Profit | $3.9M | $7.1M | $8.8M | $9.4M | $7.1M | $5.2M | $5.3M |
| General And Administrative Expense | $4.3M | $3.3M | $2.3M | $2.2M | $1.3M | $1.4M | $1.3M |
| Cost Of Revenue | $14.8M | $16.7M | $20.7M | $20.5M | $18.4M | $13.0M | $11.1M |
| Comprehensive Income Net Of Tax | -$2.3M | $1.5M | $3.5M | $3.4M | $5.2M | $3.5M | $2.3M |
| Net Income Loss Attributable To Noncontrolling Interest | -$54.7K | -$52.9K | -$43.3K | $4.9K | $18.7K | $71.6K | -$11.2K |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$2.3M | $1.4M | $3.5M | $3.4M | $5.2M | $3.5M | $2.3M |
| Deferred Income Tax Expense Benefit | $1.4K | $19.0K | $29.1K | -$7.8K | -$5.1K | ||
| Deferred Income Tax Assets Net | $1.4K | $1.3K | $2.8K | $22.3K | $49.1K | ||
| Income Taxes Paid Net | $478.7K | $2.3M | $2.4K | $115.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $57.6M | $43.9M | $35.5M | $29.6M | $26.0M | $10.5M | $7.3M | $4.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.4K | $1.5K | $1.7K | $1.9M | $53.1K | $293.8K | $820.9K | |
| Repayments Of Short Term Debt | $7.3M | $1.5M | $2.7M | $40.8K | $2.6M | $2.9M | $4.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $5.6M | $545.9K | -$728.1K | -$1.1M | $1.9M | -$240.7K | -$527.1K | |
| Cash | $80.5K | |||||||
| Inventory LIFO Reserve Period Charge | $432.8K | -$990.00 | -$5.8K | -$138.4K | -$312.5K | $29.5K | ||
| Operating Lease Right Of Use Asset Amortization Expense | $198.4K | $170.2K | $228.6K | $151.0K | $58.1K | |||
| Long Term Debt Noncurrent | $842.8K | $970.1K | $871.4K | $189.8K | $2.2M | $2.5M | ||
| Taxes Payable Current | $4.9M | $3.7M | $2.7M | $1.2M | $5.1M | $4.4M | ||
| Retained Earnings Accumulated Deficit | $16.6M | $18.7M | $18.7M | $14.7M | $9.2M | $5.1M | ||
| Property Plant And Equipment Net | $18.2M | $15.0M | $15.5M | $21.6M | $19.2M | $14.2M | ||
| Other Accrued Liabilities Current | $2.0M | $2.2M | $2.1M | $114.4K | $41.7K | $56.6K | ||
| Liabilities Current | $26.3M | $16.4M | $9.6M | $6.6M | $7.5M | $11.7M | ||
| Liabilities And Stockholders Equity | $85.2M | $61.8M | $46.6M | $37.3M | $36.4M | $25.2M | ||
| Liabilities | $27.2M | $17.4M | $10.6M | $7.2M | $9.9M | $14.2M | ||
| Inventory Net | $3.3M | $1.6M | $987.3K | $1.7M | $1.6M | $1.0M | ||
| Intangible Assets Net Excluding Goodwill | $6.4M | $777.0K | $766.4K | $366.2K | $411.1K | $141.0K | ||
| Assets Current | $45.8M | $39.8M | $24.2M | $14.7M | $16.5M | $10.8M | ||
| Assets | $85.2M | $61.8M | $46.6M | $37.3M | $36.4M | $25.2M | ||
| Additional Paid In Capital Common Stock | $40.8M | $25.0M | $18.1M | $15.7M | $15.5M | $5.3M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.9M | -$2.6M | -$3.7M | -$2.6M | $222.2K | -$388.1K | ||
| Accounts Receivable Net Current | $11.0M | $11.8M | $4.6M | $6.8M | $6.2M | $5.8M | ||
| Accounts Payable Current | $7.6M | $3.4M | $1.4M | $214.6K | $380.4K | $1.3M | ||
| Repayments Of Long Term Debt | $340.1K | $451.3K | $2.1M | $637.1K | $2.5M | |||
| Prepaid Expense And Other Assets Current | $8.7M | $4.3M | $2.4M | $277.5K | $99.0K | $7.4K | ||
| Long Term Debt Current | $1.1M | $461.8K | $419.6K | $2.1M | $448.0K | $1.2M | ||
| Minority Interest | $447.1K | $442.8K | $497.2K | $530.5K | $527.9K | $506.7K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $15.5M | $8.8M | $1.2M | $2.3M | $5.4M | $112.5K | $804.7K |
| Investing Cash Flow * | -$10.0M | -$15.7K | -$1.2M | -$3.1M | -$7.4M | -$3.0M | -$8.4M |
| Operating Cash Flow * | $141.1K | -$7.7M | -$616.9K | -$187.1K | $4.1M | $2.6M | $7.1M |
| Proceeds From Short Term Debt | $12.0M | $4.3M | $2.9M | $2.6M | $1.3M | $2.0M | $4.0M |
| Payments To Acquire Property Plant And Equipment | $6.8K | $7.0K | $61.9K | $27.7K | $51.9K | $31.9K | $213.6K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $11.7M | $7.4M | $2.2M | $265.4K | -$2.6K | -$72.1K | -$173.6K |
| Increase Decrease In Other Accrued Liabilities | $7.2M | $5.5M | $2.1M | $94.9K | -$33.1K | $46.6K | -$57.1K |
| Increase Decrease In Inventories | $2.2M | $530.6K | -$721.4K | $157.7K | $209.0K | -$1.6M | -$6.7M |
| Increase Decrease In Accrued Taxes Payable | $1.3M | $832.5K | $1.6M | -$3.6M | $410.7K | $2.7M | $1.5M |
| Increase Decrease In Accounts Receivable | $108.8K | $6.8M | -$2.1M | $1.3M | $89.5K | $284.5K | $2.9M |
| Increase Decrease In Accounts Payable | $6.1M | $1.9M | $833.5K | -$141.9K | -$969.4K | -$2.0M | -$78.4K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $7.4K | -$469.8K | -$80.8K | -$81.8K | -$111.3K | $6.8K | -$6.6K |
| Proceeds From Issuance Initial Public Offering | $10.7M | $5.6M | $2.0M | $2.0M | $11.3M | ||
| Increase Decrease In Due From Related Parties Current | $1.7M | $5.6M | $4.6M | $430.6K | $399.3K | $3.0M | -$168.9K |
| Proceeds From Longterm Loans | $970.5K | $694.0K | $1.1M | $578.3K | $1.2M | $319.3K | |
| Proceeds From Repayments Of Related Party Debt | -$578.9K | $205.2K | $10.4K | -$97.2K | -$2.3M | $1.1M | $544.0K |
| Increase Decrease In Deferred Revenue | -$276.2K | $385.8K | -$80.2K | -$875.3K | $684.0K | $161.0K | -$1.2M |
| Share Based Compensation | $1.4M | $1.3M | $349.4K | $170.9K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Common Stock Shares Authorized | 270.0M | 270.0M | 500.0M | 500.0M | 500.0M | 45.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 4.0M | 1.2M | 8.4M | 8.3M | 5.8M | 15.5M | |
| Common Stock Shares Outstanding | 4.0M | 1.2M | 8.4M | 8.3M | 5.8M | ||
| Weighted Average Number Of Shares Outstanding Basic | 2.8M | 95.5K | 36.6K | 836.1K | 6.6M | 5.2M | 5.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 2.8M | 96.1K | 36.8K | 839.6K | 6.7M | 5.2M | 5.2M |
| Earnings Per Share Diluted | $-0.72 | $4.14 | $124.92 | $7.43 | $0.68 | $0.58 | $0.50 |
| Earnings Per Share Basic | $-0.72 | $4.17 | $125.72 | $7.47 | $0.69 | $0.58 | $0.50 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Selling Expense | $436.9K | $270.6K | $293.7K | $218.8K | $138.5K | $161.7K | $273.8K |
| Investment Income Interest | $867.00 | $393.00 | $9.4K | $1.4K | $3.2K | $714.00 | $2.3K |
| Interest Paid Net | $324.0K | $303.3K | $238.2K | $446.9K | $417.3K | $276.7K | $333.2K |
| Government Subsidies | $37.3K | $63.5K | $25.4K | $1.3M | $450.0K | $362.2K | $140.3K |
| Foreign Currency Transaction Gain Loss Unrealized | -$847.00 | $35.0K | $18.8K | -$45.1K | -$248.00 | $5.3K | |
| Provision For Doubtful Accounts | $693.8K | $1.0M | $116.00 | $2.9K | $22.1K | $34.3K | |
| Short Term Borrowings | $10.2M | $5.7M | $2.5M | $2.4M | $41.4K | $1.3M | |
| Statutory Reserve | $2.8M | $2.7M | $2.4M | $1.8M | $1.1M | $579.9K |
Most recent annual filing with the SEC: January 23, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.